Can Lab-Grown tumors stop breast cancer from coming back?

NCT ID NCT05464082

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study is testing a new approach called Functional Precision Oncology for people with triple-negative or HR-low/HER2- breast cancer at high risk of early recurrence. Researchers will create personalized tumor models (in mice and lab dishes) from each patient's cancer to find the most effective treatments. The goal is to see if this method can predict and prevent the cancer from returning early. The study involves 80 participants and is currently recruiting.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Functional Precision Oncology (tumor models including patient-derived xenografts and organoids)
What this could lead to
If successful, this approach could help doctors identify the most effective treatments for each patient's unique tumor, potentially reducing the risk of early cancer return.
What could go wrong
This is a small, early-phase study (80 participants) focused on feasibility, not a proven treatment. The tumor models may not always predict real patient responses, and the approach may not improve outcomes for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER RECURRENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Huntsman Cancer Institute at University of Utah

    RECRUITING

    Salt Lake City, Utah, 84112, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.